(AOF) – Valneva (- 5.15% to 6.37 euros)
Valneva is moving again at the bottom of the index like yesterday, whether at mid-session or at the close. The Franco-Austrian vaccine manufacturer has ended its collaboration with IDT Biologika, confirming the end of its Covid adventure. The German biotech manufactured the active ingredient of Valneva’s vaccine against Covid, VLA2001. However, the latter did not receive the expected success. Orders have been so low in recent months that Valneva decided in July to suspend production. A rational but costly decision in the short term.